Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pi-Li Hu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Observation of clinical response of "sheng ban recipe" for platelets decrease after chemotherapy]Bei Zhang, Pi-Li Hu, Hui-Juan Qiu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 16, 2003
[Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma]Guo-Xian Huang, Chong Zhao, Fei Han, et al.
Medical Oncology (Northwood, London, England)|October 23, 2010
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 casesLiang-Ping Xia, Hui-Juan Qiu, Xu-Xian Chen, et al.
Cancer Biology & Medicine|May 22, 2013
Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung CancerFang Wang, Gui-Fang Guo, Hui-Juan Qiu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|September 5, 2009
[Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases]Liang-Ping Xia, Bei Zhang, Mao-Zhen Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 15, 2003
[Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC)]Ning-Ning Zhou, Zhong-Mei Zhou, Mao-Zhen Liu, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Observation of clinical response of "sheng ban recipe" for platelets decrease after chemotherapy]Bei Zhang, Pi-Li Hu, Hui-Juan Qiu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 16, 2003
[Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma]Guo-Xian Huang, Chong Zhao, Fei Han, et al.
Medical Oncology (Northwood, London, England)|October 23, 2010
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 casesLiang-Ping Xia, Hui-Juan Qiu, Xu-Xian Chen, et al.
Cancer Biology & Medicine|May 22, 2013
Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung CancerFang Wang, Gui-Fang Guo, Hui-Juan Qiu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|September 5, 2009
[Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases]Liang-Ping Xia, Bei Zhang, Mao-Zhen Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 15, 2003
[Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC)]Ning-Ning Zhou, Zhong-Mei Zhou, Mao-Zhen Liu, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Pageof 1